Saturday 17 October 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024. In the quarter to June 2026, revenue grew 66.9%, EPS grew 341.2%, free cash flow grew 152.8% and total debt fell 1.51%, each against the same quarter a year earlier. Member of the Nasdaq 100; revenue growth for five consecutive years.

231.83 2.20 −0.94%

Follow ALNY

Alert me

Market cap: $31.3B
P/E: 39.5×
Fwd P/E: 39.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	7	7	6	6	+8 more TTM periods Free account
ROE Full definition →	96.55%	90.36%	73.28%	57.72%
ROA Full definition →	15.30%	11.52%	6.82%	1.70%
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	21.16%	15.88%	10.13%	2.65%
Average Days of Receivables Full definition →	69.35	75.26	76.42	109.70
Free Cash Flow per Share Full definition →	6.14	4.84	3.55	1.68
Free Cash Flow Full definition →	819.87	643.34	465.38	221.36
Capital Expenditures Full definition →	(91.95)	(71.56)	(58.70)	(44.50)
Other line items
Cash ROIC Full definition →	14.45%	12.63%	9.89%	5.54%
Accounts Receivable Turnover Full definition →	6.49	6.59	6.28	4.87
Accounts Payable Turnover Full definition →	9.29	7.34	6.68	5.49
Inventory Turnover Full definition →	11.58	10.99	8.46	6.83
Average Days of Payables Full definition →	40.34	56.23	61.94	83.02
Days of Inventory on Hand Full definition →	36.26	37.31	44.28	53.22
Tax Rate Full definition →	0.01	(0.02)	(0.03)	56.60
Research and Development Expense of Revenue Full definition →	31.41%	33.11%	35.54%	38.87%
Selling, General and Administrative Expense of Revenue Full definition →	27.43%	30.17%	32.60%	36.78%
Share Based Compensation of Revenue Full definition →	7.01%	8.44%	9.38%	11.47%
Interest Coverage Full definition →	3.52	2.85	1.99	1.30
Operating CF/Net income Full definition →	1.18	1.33	1.67	3.46
Depreciation/Fixed assets Full definition →	0.10	0.11	0.11	0.11
Capex/Depreciation Full definition →	(1.68)	(1.31)	(1.05)	(0.79)
Revenue per Share Full definition →	35.96	32.26	28.35	24.42
Operating CF per Share Full definition →	6.82	5.38	4.00	2.02
Capex per Share Full definition →	(0.69)	(0.54)	(0.45)	(0.34)
Capex to Sales Full definition →	0.02	0.02	0.02	0.01

Show all line items

Columns are period end dates

Stockrow Weekly